FDA Approved: NEBIVOLOL — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original ANDA for Nebivolol, a generic beta-1 blocker indicated for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL)